FACTOID # 34: Malaysia has the lowest rate of cinema attendance in the world.
 
 Home   Encyclopedia   Statistics   Countries A-Z   Flags   Maps   Education   Forum   FAQ   About 
 
WHAT'S NEW
RECENT ARTICLES
More Recent Articles »
 

Encyclopedia > Schering
Schering AG
Image:Schering logo.gif
Slogan Making medicine work
Type Public
Founded 1851
Headquarters Berlin-Wedding, Germany
Key people Hubertus Erlen, CEO
Industry Pharmaceutical
Products Gynaecology & Andrology
Special therapeutics
Diagnostical devices & Nuclear medicine
Oncology
Revenue € 5 billion (2003)
Employees 26,000 (2004)
Website www.schering.de
For the American pharmaceutical company created by seizure of assets from Schering AG during World War II, see Schering-Plough.

Schering AG (FWB:SCH, NYSE: SHR) is a research-centered pharmaceutical company founded in 1851. It employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany. Schering's annual gross revenue was nearly € 5 billion (2003). Image File history File links Schering_logo. ... Look up Slogan in Wiktionary, the free dictionary. ... A public company is a company owned by the public rather than by a relatively few individuals. ... 1851 (MDCCCLI) was a common year starting on Wednesday (see link for calendar) of the Gregorian calendar (or a common year starting on Friday of the 12-day-slower Julian calendar). ... Wedding (German der Wedding) is a district in the borough of Mitte, Berlin, Germany and was a separate borough in northwestern Berlin until it was fused with Tiergarten and Mitte in 2001. ... Pharmacology (in Greek: pharmacon is drug, and logos is science) is the study of how chemical substances interfere with living systems. ... The shamefulness associated with the examination of female genitalia has long inhibited the science of gynaecology. ... Andrology (from the Greek andros, man) is the medical specialty that deals with male health, particularly relating to the problems of the male reproductive system and urological problems that are unique to men. ... Nuclear medicine is a branch of medicine and medical imaging that uses unsealed radioactive substances in diagnosis and therapy. ... Oncology is the medical subspecialty dealing with the study and treatment of cancer. ... Revenue is a U.S. business term for the amount of money that a company earns from its activities in a given period, mostly from sales of products and/or services to customers. ... Employment is a contract between two parties, one being the employer and the other being the employee. ... This page as shown in the AOL 9. ... Schering-Plough Corporation is a pharmaceutical company started in Germany by Ernst Schering in 1851. ... The German term Aktiengesellschaft (IPA /aktsiÉ™ngÉ™zεlʃaft/) (abbreviated AG) means a corporation which is limited by shares, , owned by shareholders. ... The Frankfurt Stock Exchange (outside) The DAX chart (inside) The Frankfurt Stock Exchange (German: FWB® Frankfurter Wertpapierbörse) is a stock exchange located in Frankfurt, Germany. ... New York Stock Exchange (June 2003) The New York Stock Exchange (NYSE) , also nicknamed the Big Board, is the largest stock exchange in the world in dollar volume and second largest by number of companies listed. ... A pharmaceutical company, or drug company, is a company licensed to discover, develop, market and distribute drugs. ... 1851 (MDCCCLI) was a common year starting on Wednesday (see link for calendar) of the Gregorian calendar (or a common year starting on Friday of the 12-day-slower Julian calendar). ... Wedding (German der Wedding) is a district in the borough of Mitte, Berlin, Germany and was a separate borough in northwestern Berlin until it was fused with Tiergarten and Mitte in 2001. ...


Schering AG focuses on the following business areas:

The company's founder was Ernst Schering. The shamefulness associated with the examination of female genitalia has long inhibited the science of gynaecology. ... Andrology (from the Greek andros, man) is the medical specialty that deals with male health, particularly relating to the problems of the male reproductive system and urological problems that are unique to men. ... Nuclear medicine is a branch of medicine and medical imaging that uses unsealed radioactive substances in diagnosis and therapy. ... Oncology is the medical subspecialty dealing with the study and treatment of cancer. ...


The largest German manufacturing facility is located in Bergkamen. Bergkamen is a town and a municipality in the district of Unna, in North Rhine-Westphalia, Germany. ...


Schering best-known product is probably the birth control pill. Oral contraceptives are chemicals taken by mouth to inhibit normal fertility. ...


Schering uses the Berlex Laboratories brand in the USA. // Introduction Berlex Laboratories, Incorporated is a research-based pharmaceutical company headquartered in Montville, New Jersey with operations in Wayne, New Jersey; Bothell, Washington; Seattle, Washington; and Richmond, California. ...


Bayer's Takeover Bid

On March 13, 2006, Merck KGaA announced a €14.6bn bid for Schering [1]. The offer document is due to be issued in early April 2006. March 13 is the 72nd day of the year in the Gregorian calendar (73rd in leap years). ... 2006 (MMVI) is a common year starting on Sunday of the Gregorian calendar. ... Merck KGaA is a German based pharmaceutical company. ...


Merck's takeover bid was surpassed by Bayer's $19.5B white-knight bid for Schering on March 23, 2006. In June 2006 Bayer finally bought the majority of shares, over 90%. A domination agreement is pending. Bayer AG (German pronunciation BYE-er, in US usually pronounced BAY-er) (NYSE: BAY, TYO: 4863 ) is a German chemical and pharmaceutical company founded in 1863. ... In business, a white knight may be a corporation, a private company, or a person that intends to help another firm. ...


External link


  Results from FactBites:
 
Complaint: SEC v. Schering-Plough Corporation (2266 words)
Finally, Schering disclosed in its Form 10-Q that it expected U.S. wholesalers to deplete their prescription Claritin inventories by year end, with the majority being worked down in the third-quarter, and that it expected this to have an approximately $250 million negative impact on Schering's pretax profits for the remainder of 2002.
Several months earlier, Schering had publicly warned that it expected its third-quarter earnings to be "significantly lower than the comparable period in 2001," but the company had never publicly commented on Wall Street analysts' earnings estimates for the quarter nor provided any other quantitative guidance suggesting that estimates were too high.
Schering subsequently reported actual EPS of $0.29 for the third quarter and $1.34 for the full 2002 fiscal year, while lowering its EPS guidance for the full 2003 fiscal year to a range of $0.75 to $0.85.
  More results at FactBites »

 

COMMENTARY     


Share your thoughts, questions and commentary here
Your name
Your location
Your comments
Please enter the 5-letter protection code


Lesson Plans | Student Area | Student FAQ | Reviews | Press Releases |  Feeds | Contact
The Wikipedia article included on this page is licensed under the GFDL.
Images may be subject to relevant owners' copyright.
All other elements are (c) copyright NationMaster.com 2003-5. All Rights Reserved.
Usage implies agreement with terms.